258508-84-8

Upstream product

• 91133-73-2 methyl 2-acetamido-6-methylbenzoate 
• 66232-41-5 6-methyl-2-acetylaminobenzoic acid 
• 258508-82-6 6-bromo-5-methyl-1H-benzo[d][1,3]oxazine-2,4-dione 
• 4389-50-8 2-amino-6-methylbenzoic acid 
• 20877-81-0 5-methyl-1H-benzo[d][1,3]oxazine-2,4-dione 
• 67-56-1 methanol 
• 258508-83-7 6-bromo-5-methyl-8-nitro-1H-benzo[d][1,3]oxazine-2,4-dione 

Downstream Products

• 258508-85-9 methyl 2,3-diamino-6-methyl benzoate 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUND

Provided is a heterocyclic compound that can have an antagonistic action on an NMDA receptor containing the NR2B subunit, and is expected to be useful as a prophylactic or therapeutic agent for major depression, bipolar disorder, migraine, pain, periphera

Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents

Described are neuroprotective agents of Formula I wherein R is an amino acid or nitrogen heterocyclic ring which is saturated or unsaturated of from 5 to 8 members which may have additional oxygen or sulfur atoms therein. The other provisions or substitue

Synthesis of novel quinoxaline-5-carboxylic acid derivatives

This paper describes the synthesis of several new 2,3-dimethoxy-6- methyl-7-nitro-quinoxaline-5-carboxylic acid derivatives (13a-m) via a multistep synthetic route from 5-methyl-1H-benzo[d][1,3]oxazine-2,4-dione (1).